Theranostics in Interventional Oncology: Versatile Carriers for Diagnosis and Targeted Image-Guided Minimally Invasive Procedures.

Détails

ID Serval
serval:BIB_871EAEDDCDA1
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Titre
Theranostics in Interventional Oncology: Versatile Carriers for Diagnosis and Targeted Image-Guided Minimally Invasive Procedures.
Périodique
Frontiers in pharmacology
Auteur(s)
Degrauwe N., Hocquelet A., Digklia A., Schaefer N., Denys A., Duran R.
ISSN
1663-9812 (Print)
ISSN-L
1663-9812
Statut éditorial
Publié
Date de publication
2019
Peer-reviewed
Oui
Volume
10
Pages
450
Langue
anglais
Notes
Publication types: Journal Article ; Review
Publication Status: epublish
Résumé
We are continuously progressing in our understanding of cancer and other diseases and learned how they can be heterogeneous among patients. Therefore, there is an increasing need for accurate characterization of diseases at the molecular level. In parallel, medical imaging and image-guided therapies are rapidly developing fields with new interventions and procedures entering constantly in clinical practice. Theranostics, a relatively new branch of medicine, refers to procedures combining diagnosis and treatment, often based on patient and disease-specific features or molecular markers. Interventional oncology which is at the convergence point of diagnosis and treatment employs several methods related to theranostics to provide minimally invasive procedures tailored to the patient characteristics. The aim is to develop more personalized procedures able to identify cancer cells, selectively reach and treat them, and to assess drug delivery and uptake in real-time in order to perform adjustments in the treatment being delivered based on obtained procedure feedback and ultimately predict response. Here, we review several interventional oncology procedures referring to the field of theranostics, and describe innovative methods that are under development as well as future directions in the field.
Mots-clé
HCC, SIRT, ablation, cancer, interventional oncology, radioembolization, theranostics, transarterial chemoembolization
Pubmed
Web of science
Open Access
Oui
Création de la notice
18/06/2019 17:45
Dernière modification de la notice
20/08/2019 15:46
Données d'usage